Renew to stay connected, advance neuropsychology, access resources, and drive the field forward together.
Jin Zhou, M.D., Ph.D.Executive Director Clinical Development, Neurology
Jin Zhou, M.D., Ph.D., serves as Executive Director of Clinical Development, Clinical Evidence Generation, Deep Human Biology Learning at Eisai Inc. In this role, Dr. Zhou leads the company’s late phase global clinical programs in Alzheimer’s Disease and is responsible for the clinical development strategy and trial execution for anti-amyloid and anti-tau antibodies, as well as in charge of the company’s global phase 3 AHEAD 3-45 and DIAN-TU Tau Next Generation clinical trials.
Dr. Zhou has 18 years of clinical research and pharmaceutical industry experience focusing on Neurology. She has extensive regulatory submission and interaction experience with health authorities. She joined Eisai in 2019 in Clinical Research Neurology Business Group and worked in Alzheimer’s Disease area. She is also Eisai’s representative in the AD consortia and taskforce with academic and industry collaborators.Prior to joining Eisai, Dr. Zhou held a series of clinical development positions at Daiichi Sankyo Inc., Pfizer Inc., and AstraZeneca Pharmaceuticals in Specialty Medicines and Neuroscience.
Dr. Zhou earned her medical degree and completed neurology training at Capital Medical University in Beijing, China. She completed her Ph.D. in Neuroscience at University of Illinois at Chicago, and postdoc fellowship at Rockefeller University in New York.